Endoplasmic Reticulum Stress and the Hallmarks of Cancer

Trends in Cancer

Volumn 2, Issue 5, 2016, Pages 252-262

  Urra, Hery ^a,b,c   Dufey, Estefanie ^a,b,c   Avril, Tony ^d,e   Chevet, Eric ^d,e   Hetz, Claudio ^a,b,c,f,g  

^a UNIVERSITY OF CHILE   (Chile)

^b Universidad de Chile and Geroscience Center for Brain Health and Metabolism   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d INSERM   (France)

^e Centre de Lutte Contre le Cancer Eugene Marquis   (France)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

cancer; ER stress; IRE1 ; UPR; XBP1

Indexed keywords

ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; CARCINOGENESIS; CELL INVASION; CELL TRANSFORMATION; ENDOPLASMIC RETICULUM STRESS; EPIGENETICS; GENOMIC INSTABILITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; REVIEW; TUMOR INVASION; UNFOLDED PROTEIN RESPONSE; ANIMAL; DRUG RESISTANCE; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM STRESS; EPIGENESIS, GENETIC; GENOMIC INSTABILITY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; UNFOLDED PROTEIN RESPONSE;

EID: 84968918504     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2016.03.007     Document Type: Review

References (103)

1. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
2. Y. Ma, and L.M. Hendershot The role of the unfolded protein response in tumour development: friend or foe? Nat. Rev. Cancer 4 2004 966 977
3. D. Ruggero Translational control in cancer etiology Cold Spring Harb. Perspect. Biol. 5 2013 a012336
4. N. Dejeans, and et al. Addicted to secrete-novel concepts and targets in cancer therapy Trends Mol. Med. 20 2014 242 250
5. C. Hetz The unfolded protein response: controlling cell fate decisions under ER stress and beyond Nat. Rev. Mol. Cell Biol. 13 2012 89 102
6. H.J. Clarke, and et al. Endoplasmic reticulum stress in malignancy Cancer cell 25 2014 563 573
7. M. Bi, and et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth EMBO J. 24 2005 3470 3481
8. J.D. Blais, and et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress Mol. Cell Biol. 26 2006 9517 9532
9. A.S. Lee Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential Nat. Rev. Cancer 14 2014 263 276
10. A.S. Lee GRP78 induction in cancer: therapeutic and prognostic implications Cancer Res. 67 2007 3496 3499
11. E. Chevet, and et al. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis Cancer Discov. 5 2015 586 597
12. E. Dufey, and et al. ER proteostasis addiction in cancer biology: novel concepts Semin. Cancer Biol. 33 2015 40 47
13. C. Hetz, and et al. Proteostasis control by the unfolded protein response Nat. Cell Biol. 17 2015 829 838
14. E. Dufey, and et al. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 1. An overview Am. J. Physiol. Cell Physiol. 307 2014 C582 C594
15. C. Hetz, and et al. Targeting the unfolded protein response in disease Nat. Rev. Drug Discov. 12 2013 703 719
16. Y. Lu, and et al. A synthetic biology approach identifies the mammalian UPR RNA ligase RtcB Mol. Cell 55 2014 758 770
17. P. Walter, and D. Ron The unfolded protein response: from stress pathway to homeostatic regulation Science 334 2011 1081 1086
18. M. Maurel, and et al. Getting RIDD of RNA: IRE1 in cell fate regulation Trends Biochem. Sci. 39 2014 245 254
19. H. Urra, and et al. When ER stress reaches a dead end Biochim. Biophys. Acta. 1833 2013 3507 3517
20. S.J. Marciniak, and et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum Genes. Dev. 18 2004 3066 3077
21. P. Tsaytler, and et al. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis Science 332 2011 91 94
22. D.W. Reid, and et al. The unfolded protein response triggers selective mRNA release from the endoplasmic reticulum Cell 158 2014 1362 1374
23. C. Denoyelle, and et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway Nat. Cell Biol. 8 2006 1053 1063
24. A.L. Huber, and et al. p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose Mol. Cell 49 2013 1049 1059
25. S.B. Cullinan, and et al. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Society 23 2003 7198 7209
26. C.A. Del Vecchio, and et al. De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling PLoS Biol. 12 2014 e1001945
27. W. Zhang, and et al. ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation Genes. Dev. 27 2013 441 449
28. D. Pytel, and et al. Tumor progression and the different faces of the PERK kinase Oncogene 35 2015 1207 1215
29. C. Atkins, and et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity Cancer Res. 73 2013 1993 2002
30. J.M. Axten, and et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) J. Med. Chem. 55 2012 7193 7207
31. O. Pluquet, and et al. Posttranscriptional regulation of PER1 underlies the oncogenic function of IREalpha Cancer Res. 73 2013 4732 4743
32. X. Chen, and et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway Nature 508 2014 103 107
33. B. Kharabi Masouleh, and et al. Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia Proc. Natl. Acad. Sci. U.S.A. 111 2014 E2219 E2228
34. D.R. Carrasco, and et al. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis Cancer cell 11 2007 349 360
35. M. Nakamura, and et al. Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells Leuk. Lymphoma 47 2006 531 539
36. N. Mimura, and et al. Blockade of XBP1 splicing by inhibition of IRE1alpha is a promising therapeutic option in multiple myeloma Blood 119 2012 5772 5781
37. I. Papandreou, and et al. Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma Blood 117 2011 1311 1314
38. M. Ri, and et al. Identification of toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing Blood cancer J. 2 2012 e79
39. C. Greenman, and et al. Patterns of somatic mutation in human cancer genomes Nature 446 2007 153 158
40. R. Ghosh, and et al. Allosteric inhibition of the IRE1alpha RNase preserves cell viability and function during endoplasmic reticulum stress Cell 158 2014 534 548
41. Z. Xue, and et al. A conserved structural determinant located at the interdomain region of mammalian inositol-requiring enzyme 1α J. Biol. Chem. 286 2011 30859 30866
42. A.N. Shajahan, and et al. The role of X-box binding protein-1 in tumorigenicity Drug News Perspect. 22 2009 241 246
43. G. Auf, and et al. Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma Proc. Natl. Acad. Sci. U.S.A. 107 2010 15553 15558
44. N. Dejeans, and et al. Autocrine control of glioma cells adhesion and migration through IRE1alpha-mediated cleavage of SPARC mRNA J. Cell Sci. 125 2012 4278 4287
45. D. Jiang, and et al. Targeting the IRE1alpha-XBP1 branch of the unfolded protein response in human diseases Semin. Cancer Biol. 33 2015 48 56
46. R.K. Jain Molecular regulation of vessel maturation Nat. Med. 9 2003 685 693
47. E.R. Pereira, and et al. Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response PLoS One 5 2010 e12521
48. F. Binet, and P. Sapieha ER stress and angiogenesis Cell Metab. 22 2015 560 575
49. Y. Wang, and et al. The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway Cancer Res. 72 2012 5396 5406
50. L. Zeng, and et al. Vascular endothelial cell growth-activated XBP1 splicing in endothelial cells is crucial for angiogenesis Circulation 127 2013 1712 1722
51. E. Karali, and et al. VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress Mol. Cell 54 2014 559 572
52. E.R. Pereira, and et al. Endoplasmic reticulum (ER) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 (HIF-1) transcriptional activity on targets like vascular endothelial growth factor (VEGF) J. Biol. Chem. 289 2014 3352 3364
53. H. Urra, and C. Hetz A novel ER stress-independent function of the UPR in angiogenesis Mol. Cell 54 2014 542 544
54. N.R. Mahadevan, and et al. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells Proc. Natl. Acad. Sci. U.S.A. 108 2011 6561 6566
55. + T cell priming PLoS One 7 2012 e51845
56. P. Mardones, and et al. Control of systemic proteostasis by the nervous system Trends Cell Biol. 25 2015 1 10
57. N.N. Iwakoshi, and et al. The transcription factor XBP-1 is essential for the development and survival of dendritic cells J. Exp. Med. 204 2007 2267 2275
58. + dendritic cells Nat. Immunol. 15 2014 248 257
59. J.R. Cubillos-Ruiz, and et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis Cell 161 2015 1527 1538
60. P.T. Thevenot, and et al. The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors Immunity 41 2014 389 401
61. J.A. Aguirre-Ghiso Models, mechanisms and clinical evidence for cancer dormancy Nat. Rev. Cancer 7 2007 834 846
62. D. Paez, and et al. Cancer dormancy: a model of early dissemination and late cancer recurrence Clin. Cancer Res. 18 2012 645 653
63. M.A. Ginos, and et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck Cancer Res. 64 2004 55 63
64. Y.H. Lin, and et al. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer Clin. Cancer Res. 13 2007 498 507
65. S. Ramaswamy, and et al. Multiclass cancer diagnosis using tumor gene expression signatures Proc. Natl. Acad. Sci. U.S.A. 98 2001 15149 15154
66. D.M. Schewe, and J.A. Aguirre-Ghiso ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo Proc. Natl. Acad. Sci. U.S.A. 105 2008 10519 10524
67. M. Arai, and et al. Transformation-associated gene regulation by ATF6alpha during hepatocarcinogenesis FEBS Lett. 580 2006 184 190
68. A. Higa, and et al. Endoplasmic reticulum stress-activated transcription factor ATF6alpha requires the disulfide isomerase PDIA5 to modulate chemoresistance Mol. Cell Biol. 34 2014 1839 1849
69. J.A. Thorpe, and S.R. Schwarze IRE1alpha controls cyclin A1 expression and promotes cell proliferation through XBP-1 Cell Stress Chaperones 15 2010 497 508
70. J.W. Brewer, and J.A. Diehl PERK mediates cell-cycle exit during the mammalian unfolded protein response Proc. Natl. Acad. Sci. U.S.A. 97 2000 12625 12630
71. A.C. Ranganathan, and et al. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells Cancer Res. 66 2006 1702 1711
72. L. Galluzzi, and et al. Immunological effects of conventional chemotherapy and targeted anticancer agents Cancer cell 28 2015 690 714
73. E. Bobrovnikova-Marjon, and et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage Oncogene 29 2010 3881 3895
74. K.A. Henry, and et al. The unfolded protein response is not necessary for the G1/S transition, but it is required for chromosome maintenance in Saccharomyces cerevisiae PLoS One 5 2010 e12732
75. A.A. Farooqi, and et al. Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress Tumour Biol. 36 2015 5743 5752
76. L. He, and et al. ATM blocks tunicamycin-induced endoplasmic reticulum stress FEBS Lett. 583 2009 903 908
77. N. Dioufa, and et al. p53 antagonizes the unfolded protein response and inhibits ground glass hepatocyte development during endoplasmic reticulum stress Exp. Biol. Med. 237 2012 1173 1180
78. D. Acosta-Alvear, and et al. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks Mol. Cell 27 2007 53 66
79. A.B. Oromendia, and et al. Aneuploidy causes proteotoxic stress in yeast Genes. Dev. 26 2012 2696 2708
80. D. Zhang, and et al. Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation Cardiovasc. Res. 109 2016 519 526
81. C. Yang, and et al. Proteostasis modulators prolong missense VHL protein activity and halt tumor progression Cell Rep. 3 2013 52 59
82. C. Boyault, and et al. HDAC6-p97/VCP controlled polyubiquitin chain turnover EMBO J. 25 2006 3357 3366
83. E. Marza, and et al. Genome-wide screen identifies a novel p97/CDC-48-dependent pathway regulating ER-stress-induced gene transcription EMBO Rep. 16 2015 332 340
84. N. Dicks, and et al. Endoplasmic reticulum stress, genome damage, and cancer Front. Oncol. 5 2015 11
85. A.W. Schram, and et al. A dual role for SAGA-associated factor 29 (SGF29) in ER stress survival by coordination of both histone H3 acetylation and histone H3 lysine-4 trimethylation PLoS One 8 2013 e70035
86. Y.X. Feng, and et al. Epithelial-to-mesenchymal transition activates PERK-eIF2alpha and sensitizes cells to endoplasmic reticulum stress Cancer Discov. 4 2014 702 715
87. N. Sheshadri, and et al. SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling Cancer Res. 74 2014 6318 6329
88. K.M. Rouschop, and et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 J. Clin. Invest. 120 2010 127 141
89. H. Mujcic, and et al. Hypoxic activation of the PERK/eIF2alpha arm of the unfolded protein response promotes metastasis through induction of LAMP3 Clin. Cancer Res. 19 2013 6126 6137
90. A. Nagelkerke, and et al. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response Breast Cancer Res. 15 2013 R2
91. A. Nagelkerke, and et al. Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinoma Head Neck 37 2014 896 905
92. H. Zhu, and et al. Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients PLoS One 9 2014 e103882
93. M. Wang, and R.J. Kaufman The impact of the endoplasmic reticulum protein-folding environment on cancer development Nat. Rev. Cancer 14 2014 581 597
94. S. Martin, and et al. Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78 Br. J. Cancer. 109 2013 433 443
95. A. Prabhu, and et al. Targeting the unfolded protein response in glioblastoma cells with the fusion protein EGF-SubA PLoS One 7 2012 e52265
96. P. Pyrko, and et al. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas Cancer Res. 67 2007 9809 9816
97. B. Drogat, and et al. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo Cancer Res. 67 2007 6700 6707
98. A. Jabouille, and et al. Glioblastoma invasion and cooption depend on IRE1alpha endoribonuclease activity Oncotarget 6 2015 24922 24934
99. X. Hou, and et al. PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation Sci. Rep. 5 2015 9065
100. H.A. Hamed, and et al. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins Cancer Biol. Ther. 9 2010 526 536
101. A. Yacoub, and et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells Cancer Res. 70 2010 1120 1129
102. D.Y. Dadey, and et al. The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma Oncotarget 7 2016 2080 2092
103. C.M. Toledo, and et al. Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in glioblastoma stem-like cells Cell Rep. 13 2015 2425 2439